Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (1.074)
1
Study of safety and efficacy of CFZ533 in kidney transplant patients : A partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability,pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and maintenance kidney transplant recipients (CIRRUS I) - CIRRUS I
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Envarsus versus twice-daily tacrolimus as immunosuppression in kidney transplantation : AGe-adapted benefits of Envarsus versus twice-daily tacrolimus ImmunosuppressioN druGs after kidney transplantation (AGEING) – a feasibility study - AGEING 1.0
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Efficacy and safety of human plasma-derived C1-esterase inhibitor as add-on to standard of care for the treatment of refractory antibody mediated rejection (AMR) in adult renal transplant recipients : A Double-blind, Randomized-Withdrawal, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Human Plasma-Derived C1-esterase Inhibitor as Add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Study of safety and efficacy of CFZ533 in kidney transplant patients : A partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability,pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and maintenance kidney transplant recipients (CIRRUS I) - CIRRUS I
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Envarsus versus twice-daily tacrolimus as immunosuppression in kidney transplantation : AGe-adapted benefits of Envarsus versus twice-daily tacrolimus ImmunosuppressioN druGs after kidney transplantation (AGEING) – a feasibility study - AGEING 1.0
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Efficacy and safety of human plasma-derived C1-esterase inhibitor as add-on to standard of care for the treatment of refractory antibody mediated rejection (AMR) in adult renal transplant recipients : A Double-blind, Randomized-Withdrawal, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Human Plasma-Derived C1-esterase Inhibitor as Add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[108]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
1.074
Aufsätze
1.074
E-Artikel
1.074
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.074
610
970
Study Type: Interventional
596
Recruitment Status: Not yet recruiting
164
Recruitment Status: Completed
162
Phase: Phase 4
152
Recruitment Status: Authorised-recruitment may ...
118
Phase: Phase 2
116
Phase: Phase 3
82
Recruitment Status: Recruiting
72
Study Type: Observational
40
Medical Condition: renal transplantation
36
Recruitment Status: Complete: follow-up complete
30
Medical Condition: Renal transplantation MedDRA...
24
Phase: Phase 1
18
Medical Condition: Renal transplantation
16
Medical Condition: Prophylaxis of rejection in ...
16
Phase: Post-market
14
Medical Condition: Renal Transplantation
12
Medical Condition: Prophylaxis of rejection in ...
12
Medical Condition: Refractory AMR in adult rena...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
400
2020-
674
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.024
Englisch
24
Unbestimmt
14
Spanisch
12
Französisch
Haven't found what you're looking for?
Wird geladen...